Your browser doesn't support javascript.
loading
Corrigendum to "Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial": Annals of Oncology 2012; 23: 1818-1825.
Behringer, K; Thielen, I; Mueller, H; Goergen, H; Eibl, A D; Rosenbrock, J; Halbsguth, T; Eichenauer, D A; Fuchs, M; Reiners, K S; Renno, J H; van der Ven, K; Kuehr, M; von Wolff, M; Diehl, V; Engert, A; Borchmann, P.
Afiliação
  • Behringer K; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Thielen I; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Mueller H; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Goergen H; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Eibl AD; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Rosenbrock J; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Halbsguth T; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Eichenauer DA; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Fuchs M; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Reiners KS; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Renno JH; Institute for Clinical Chemistry, University of Cologne, Cologne, Germany.
  • van der Ven K; Department of Gynecological Endocrinology and Reproductive Medicine, University of Bonn, Bonn, Germany.
  • Kuehr M; Department of Gynecological Endocrinology and Reproductive Medicine, University of Bonn, Bonn, Germany.
  • von Wolff M; Department of Gynecological Endocrinology and Reproductive Medicine, University Women's Hospital, Bern, Switzerland.
  • Diehl V; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Engert A; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany.
  • Borchmann P; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, First Department of Internal Medicine, UniversityHospital of Cologne, Cologne, Germany. Electronic address: peter.borchmann@uni-koeln.de.
Ann Oncol ; 31(8): 1093, 2020 08.
Article em En | MEDLINE | ID: mdl-32553542

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article